X0508 4/A 2025-03-03 2025-03-03 false 0001645113 NovoCure Ltd NVCR 0001811030 Weinberg Uri C/O NOVOCURE INC. 1550 LIBERTY RIDGE DRIVE, SUITE 115 WAYNE PA 19087 false true false false Chief Innovation Officer false Ordinary Shares 2025-02-28 4 S false 4326.00 18.7827 D 166822.00 D Ordinary Shares 2025-02-28 4 S false 311.00 18.3128 D 166511.00 D Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. On February 28, 2025, the reporting person sold 4,326 shares in multiple trades at prices ranging from $18.73 to $18.86. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Staff, the issuer for any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected. On February 28, 2025, the reporting person sold 311 shares in multiple trades at prices ranging from $18.30 to $18.316. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Staff, the issuer for any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected. Amended to add footnote #1 to the filing. Steven Robbins, as attorney in fact for Weinberg, Uri 2025-03-03